Continuous Subcutaneous Insulin Infusion in the Treatment of Children and Adolescents with Type I Diabetes Mellitus

Author(s):  
M.-T. Saha ◽  
T. Huupponen ◽  
M. Knip ◽  
M. Juuti ◽  
J. Komulainen
2020 ◽  
Vol 6 (2) ◽  
Author(s):  
Siddig AA ◽  
Bui TDMP ◽  
Readon DR ◽  
Ven M ◽  
Bailes Z ◽  
...  

Introduction: Continuous subcutaneous insulin infusion (CSII) is a form of insulin administration for patients with type I diabetes mellitus (T1DM) that was introduced as a means of stimulating normal plasma insulin fluctuations and provide better metabolic control that is better than multiple daily insulin injections (MDI). The purpose of this study was to determine the effect of CSII as compared to MDI in the treatment of T1DM in children and adolescent below 20 years of age.


2016 ◽  
Vol 37 (3) ◽  
pp. 299-303 ◽  
Author(s):  
Vahideh Toopchizadeh ◽  
Siamak Shiva ◽  
Nader-Yousefzadeh Khiabani ◽  
Robabeh Ghergherechi

2000 ◽  
Vol 50 ◽  
pp. 416
Author(s):  
Nermin Salah ◽  
Loubna Mansour ◽  
Shereen Abdel-Ghaffar ◽  
Ann Abdel-Kader ◽  
Lamia Soubhy

Sign in / Sign up

Export Citation Format

Share Document